Vir Biotechnology, Inc. VIR

10.66 (0.06) (0.56%) as of 25 Sep
Market cap
$1.8B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
468.94 994.73 1,535.68 2,414.72 716.74 744.85 389.62 109.20 188.00
Receivables
— — — — 773.08 — — — —
Total current assets
514.08 1,042.46 1,588.23 2,519.08 1,562.82 772.37 403.00 117.78 192.00
Property, Plant, Equpment (Net)
55.62 63.18 96.02 105.61 42.83 17.95 16.31 12.29 5.00
Long-Term Investments
314.58 190.02 105.28 23.93 201.39 13.00 24.29 8.00 1.00
Goodwill and Intangible Assets (Total)
24.79 25.06 39.50 49.69 50.22 50.76 52.63 53.85 0.00
Long-term assets (Other)
31.66 18.42 18.86 21.23 9.78 15.75 15.85 7.67 0.00
Total non-current assets
488.74 356.36 330.83 283.01 391.45 146.40 109.08 73.81 —
Total Assets
1,002.82 1,398.81 1,919.06 2,802.09 1,954.27 918.76 512.07 191.60 0.00
Accounts Payable
9.80 5.08 6.33 6.42 6.52 5.08 5.88 6.47 5.00
Accrued Expenses
83.01 98.52 104.22 489.09 236.51 76.94 26.50 14.53 —
Current Part of Capital Lease
— — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — 0.00
Current Revenue (Deferred)
— 12.65 64.85 15.52 98.21 6.45 6.18 8.76 —
Other current liabilities
— 16.06 — 485.00 325.00 10.60 20.65 10.14 8.00
Total current liabilities
92.82 119.66 175.41 511.03 341.24 99.06 59.21 39.91 12.00
Non-current Revenue (Deferred)
— — 1.53 53.21 3.82 3.82 12.67 6.56 0.00
Long Term Tax Liability (Deferred)
— — — 3.25 18.44 3.25 3.31 3.31 3.00
Liabilities (Preferred Stock)
— — — — — — — 310.16 —
Minority Interests
— — — — — — — — 0.00
Non-current Liabilities (Other)
55.68 38.63 41.74 36.05 25.36 29.22 12.95 10.84 11.00
Total non-current liabilities
144.73 128.77 153.42 213.10 181.18 102.85 28.92 330.87 —
Total liabilities
237.55 248.43 328.82 724.13 522.42 201.91 88.13 370.77 0.00
Additional Paid In Capital
1,965.09 1,911.87 1,828.86 1,709.84 1,571.54 1,385.30 793.05 14.67 0.00
Preferred Stock (Total)
— — — — — — — — 0.00
Common Stock (Net)
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Retained Earnings
(1,197.77) (759.78) (237.82) 377.24 (138.60) (667.18) (368.52) (193.84) (78.00)
Treasury Stock
— — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — 0.00
Common Equity (Total)
765.28 1,150.39 1,590.24 2,077.96 1,431.85 716.85 423.94 (179.18) (69.00)
Shareholders Equity (Total)
765.28 1,150.39 1,590.24 2,077.96 1,431.85 716.85 423.94 (179.18) 0.00
Shareholders Equity and Liabilities (Total)
1,002.82 1,398.81 1,919.06 2,802.09 1,954.27 918.76 512.07 191.60 0.00
Shares (Common)
139.48 136.96 134.78 133.24 131.16 127.42 107.65 8.86 —
Shareholders Equity (Tangible)
740.49 1,125.33 1,550.73 2,028.27 1,381.63 666.10 371.31 (233.03) —
Net Debt
(468.94) (994.73) (1,535.68) (2,414.72) (716.74) (744.85) (389.62) (109.20) (188.00)
Total Debt
— — — 128.00 138.00 71.00 1.00 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates